Splash Beverage partners with Lupvindol to advance cannabidiol veterinary drug
Splash Beverage Group partners with Lupvindol Biosciences to advance CannEpil for companion-animal oncology and pain through FDA veterinary pathways, retaining ownership of resulting data and IP.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day